1. The comparison between matched samples of HBV-associated HCC individuals (primary tumor vs. portal vein tumor thromboses) reveals 65 mutations including TP53 and ARID1A.2. ARID1A mutations were also identified in four HCC cell lines with high metastatic potential. Here, ARID1A is linked to hepatocellular carcinoma.